<DOC>
	<DOCNO>NCT01755403</DOCNO>
	<brief_summary>study population pharmacokinetics Benznidazole-treated adult patient Chronic Chagas Disease get information optimize drug dos .</brief_summary>
	<brief_title>Population Pharmacokinetics Benznidazole-treated Adults With Chronic With Chagas Disease</brief_title>
	<detailed_description />
	<mesh_term>Chagas Disease</mesh_term>
	<mesh_term>Benzonidazole</mesh_term>
	<criteria>Adult patient Chronic Chagas Disease diagnose 2 different positive serological test . Patients Chronic Chagas Disease go start treatment Benznidazole . Any gender . All participant must agree participate study must sign informed consent . Patients young 18 . Patients previous hypersensitivity Benznidazole . Immunocompromised patient AIDS , cancer , chemotherapy , longterm corticoid need , primary immunodeficiency , . Hepatic dysfunction Renal dysfunction : serum creatinin high 3 mg/dl . Pregnancy lactation . Low adhesion treatment checkup . Impossibility followup . Severe adverse reaction Benznidazole . Any situation could risky patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>